Publications for Martin Krause 2016

advertisement
Publications for Martin Krause
Publications for Martin Krause
2016
Yu, S., Arima, H., Bertmar, C., Hirakawa, Y.,
Priglinger, M., Evans, K., Krause, M. (2016).
Depression but not anxiety predicts recurrent
cerebrovascular events. Acta Neurologica
Scandinavica, 134(1), 29-34. <a
href="http://dx.doi.org/10.1111/ane.12503">[Mo
re Information]</a>
O’Brien, E., Priglinger, M., Bertmar, C., Day, S.,
Borsodi, C., Herkes, G., Krause, M. (2016).
Rapid access point of care clinic for transient
ischemic attacks and minor strokes. Journal of
Clinical Neuroscience, 23, 106-110. <a
href="http://dx.doi.org/10.1016/j.jocn.2015.04.0
32">[More Information]</a>
McGrath, R., Hocking, S., Priglinger, M., Day,
S., Herkes, G., Krause, M., Fulcher, G. (2016).
Rationale and design of Short-Term EXenatide
therapy in Acute ischaemic Stroke (STEXAS): a
randomised, open-label, parallel-group study.
BMJ Open, 6(2), 1-7. <a
href="http://dx.doi.org/10.1136/bmjopen-2015-0
08203">[More Information]</a>
Yu, S., Arima, H., Heeley, E., Delcourt, C.,
Krause, M., Peng, B., Yang, J., Wu, G., Chen,
X., Chalmers, J., Anderson, C. (2016). White
blood cell count and clinical outcomes after
intracerebral hemorrhage: The INTERACT2
trial. Journal of the Neurological Sciences, 361,
112-116. <a
href="http://dx.doi.org/10.1016/j.jns.2015.12.033
">[More Information]</a>
2015
McGrath, R., Glastras, S., Hocking, S., Tjoeng,
I., Krause, M., Fulcher, G. (2015). Central
Functions of Glucagon-like Peptide-1: Roles in
Energy Regulation and Neuroprotection. Journal
of Steroids & Hormonal Science, 6(1), 1-8. <a
href="http://dx.doi.org/10.4172/2157-7536.1000.
152">[More Information]</a>
Chinthapalli, K., Newey, A., Krause, M. (2015).
Corticosteroid induced hyperosmolar
hyperglycaemic state and hemiballismus. Oxford
Medical Case Reports, 2015 (9), 320-322. <a
href="http://dx.doi.org/10.1093/omcr/omv051">[
More Information]</a>
Campbell, B., Mitchell, P., Kleinig, T., Dewey,
H., Churilov, L., Yassi, N., Yan, B., Dowling, R.,
Parsons, M., Krause, M., Priglinger, M., et al
(2015). Endovascular Therapy for Ischemic
Stroke with Perfusion-Imaging Selection. The
New England Journal of Medicine, 372(11),
1009-1018. <a
href="http://dx.doi.org/10.1056/NEJMoa141479
2">[More Information]</a>
Griffiths, D., Krause, M. (2015). Evaluation and
Management of Symptomatic Carotid Stenosis.
Austin Journal of Cerebrovascular Disease &
Stroke, 2(2), 1-6.
Priglinger, M., Krause, M. (2015). Guest
Editorial. Australasian Journal of Neuroscience,
25, 6-7.
Krause, M., Priglinger, M. (2015). Guest
editorial: Migraine Management. Australasian
Journal of Neuroscience, 25(1), 6-7.
Priglinger, M., Arima, H., Anderson, C., Krause,
M. (2015). No relationship of lipid-lowering
agents to hematoma growth: pooled analysis of
the intensive blood pressure reduction in acute
cerebral hemorrhage trials studies. Stroke, 46(3),
857-859. <a
href="http://dx.doi.org/10.1161/STROKEAHA.1
14.007664">[More Information]</a>
Carey, L., Crewther, S., Salvado, O., Linden, T.,
Connelly, A., Wilson, W., Howells, D., Churilov,
L., Ma, H., Tse, T., Krause, M., et al (2015).
STroke imAging pRevention and treatment
(START): A longitudinal stroke cohort study:
Clinical trials protocol. International Journal of
Stroke, 10(4), 636-644. <a
href="http://dx.doi.org/10.1111/ijs.12190">[Mor
e Information]</a>
Priglinger, M., Krause, M. (2015). TIAs and
stroke prevention. Rapid assessment, urgent
treatment. Cardiology Today, 5(2), 15-20.
2014
Campbell, B., Mitchell, P., Yan, B., Parsons, M.,
Christensen, S., Churilov, L., Dowling, R.,
Dewey, H., Brooks, M., Miteff, F., Krause, M.,
et al (2014). A multicenter, randomized,
controlled study to investigate EXtending the
time for Thrombolysis in Emergency
Neurological De�?cits with Intra-Arterial
therapy (EXTEND-IA). International Journal of
Stroke, 9(1), 126-132. <a
href="http://dx.doi.org/10.1111/ijs.12206">[Mor
e Information]</a>
Adam, R., Priglinger, M., Harrington, T.,
Gottlieb, D., Krause, M. (2014). An Unusual
Cause of Cerebellar Hemorrhage in a Young
Patient: Essential Thrombocythemia. Journal of
Stroke and Cerebrovascular Diseases, 23(5),
e373-e374. <a
href="http://dx.doi.org/10.1016/j.jstrokecerebrov
asdis.2013.12.013">[More Information]</a>
Phu, A., Xu, Z., Brakoulias, V., Mahant, N.,
Fung, V., De Moore, G., Martin, A., Starcevic,
V., Krause, M. (2014). Effect of impulse control
disorders on disability and quality of life in
Parkinson's disease patients. Journal of Clinical
Neuroscience, 21(1), 63-66. <a
href="http://dx.doi.org/10.1016/j.jocn.2013.02.0
Publications for Martin Krause
32">[More Information]</a>
Ma, C., Evans, K., Bertmar, C., Krause, M.
(2014). Predictive value of the Royal Melbourne
Hospital Falls Risk Assessment Tool (RMH
FRAT) for post-stroke patients. Journal of
Clinical Neuroscience, 21(4), 607-611. <a
href="http://dx.doi.org/10.1016/j.jocn.2013.06.0
18">[More Information]</a>
2013
Griffiths, D., Newey, A., Faulder, K., Steinfort,
B., Krause, M. (2013). Thrombosis of a
Developmental Venous Anomaly Causing
Venous Infarction and Pontine Hemorrhage.
Journal of Stroke and Cerebrovascular Diseases,
22(8), e653-655. <a
href="http://dx.doi.org/10.1016/j.jstrokecerebrov
asdis.2013.04.033">[More Information]</a>
2012
Ma, H., Parsons, M., Christensen, S., Campbell,
B., Churilov, L., Connelly, A., Yan, B., Bladin,
C., Phan, T., Barber, A., Krause, M., et al (2012).
A multicentre, randomized, double-blinded,
placebo-controlled Phase III study to investigate
EXtending the time for Thrombolysis in
Emergency Neurological Deficits (EXTEND).
International Journal of Stroke, 7(1), 74-80. <a
href="http://dx.doi.org/10.1111/j.1747-4949.201
1.00730.x">[More Information]</a>
Krause, M., Mahant, N., Kotschet, K., Fung, V.,
Vagg, D., Wong, C., Morris, J. (2012).
Dysexecutive behaviour following deep brain
lesions - A different type of disconnection
syndrome? Cortex, 48(1), 97-119. <a
href="http://dx.doi.org/10.1016/j.cortex.2011.03.
014">[More Information]</a>
Volkmann, J., Wolters, A., Kupsch, A., Muller,
J., Kuhn, A., Schneider, G., Poewe, W., Hering,
S., Eisner, W., Muller, J., Krause, M., et al
(2012). Pallidal deep brain stimulation in patients
with primary generalised or segmental dystonia:
5-year follow-up of a randomised trial. The
Lancet Neurology, 11(12), 1029-1038. <a
href="http://dx.doi.org/10.1016/S1474-4422(12)
70257-0">[More Information]</a>
Sandercock, P., Wardlaw, J., Lindley, R.,
Dennis, M., Cohen, G., Murray, G., Innes, K.,
Venables, G., Czlonkowska, A., Kobayashi, A.,
et al (2012). The benefits and harms of
intravenous thrombolysis with recombinant
tissue plasminogen activator within 6 h of acute
ischaemic stroke (the third international stroke
trial [IST-3]): a randomised controlled trial. The
Lancet, 379(9834), 2352-2363. <a
href="http://dx.doi.org/10.1016/S0140-6736(12)
60768-5">[More Information]</a>
2011
Sandercock, P., Lindley, R., Wardlaw, J.,
Dennis, M., Innes, K., Cohen, G., Whiteley, W.,
Perry, D., Soosay, V., Buchanan, D., et al (2011).
Update on the third international stroke trial
(IST- 3) of thrombolysis for acute ischaemic
stroke and baseline features of the 3035 patients
recruited. Trials, 12(252), 1-9. <a
href="http://dx.doi.org/10.1186/1745-6215-12-2
52">[More Information]</a>
2010
Daniels, C., Krack, P., Volkmann, J., Pinsker,
M., Krause, M., Tronnier, V., Kloss, M.,
Schnitzler, A., Wojtecki, L., Bötzel, K., et al
(2010). Risk factors for executive dysfunction
after subthalamic nucleus stimulation in
Parkinson's disease. Movement Disorders,
25(11), 1583-1589. <a
href="http://dx.doi.org/10.1002/mds.23078">[M
ore Information]</a>
2008
Witt, K., Daniels, C., Reiff, J., Krack, P.,
Volkmann, J., Pinsker, M., Krause, M., Tronnier,
V., Schnitzler, A., Hilker, R., et al (2008).
Neuropsychological and psychiatric changes
after deep brain stimulation for Parkinson's
disease: a randomised, multicentre study. The
Lancet Neurology, 7(7), 605-614. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=18538636">[More Information]</a>
Mueller, J., Skogseid, I., Benecke, R.,
Volkmann, J., Kupsch, A., Trottenberg, T.,
Poewe, W., Schnitzler, A., Krause, M., Brentrup,
A., et al (2008). Pallidal deep brain stimulation
improves quality of life in segmental and
generalized dystonia: Results from a prospective,
randomized sham-controlled trial. Movement
Disorders, 23(1), 131-134. <a
href="http://dx.doi.org/10.1002/mds.21783">[M
ore Information]</a>
2007
Szabo, K., Hirsch, J., Krause, M., Ende, G.,
Henn, F., Sartorius, A., Gass, A. (2007).
Diffusion weighted MRI in the early phase after
electroconvulsive therapy. Neurological
research, 29(3), 256-259. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17509223">[More Information]</a>
Henninger, N., Wang, Q., Okun, J., Schwab, S.,
Krause, M. (2007). Nitrous oxide promotes
hyperhomocysteinemia in levodopa treated rats.
Parkinsonism and Related Disorders, 13(8),
524-527. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17240187">[More Information]</a>
Publications for Martin Krause
2006
Deuschl, G., Schade-Brittinger, C., Krack, P.,
Volkmann, J., Schäfer, H., Bötzel, K., Daniels,
C., Deutschländer, A., Dillmann, U., Krause, M.,
et al (2006). A randomized trial of deep-brain
stimulation for Parkinson's disease. New England
Journal of Medicine, 355(9), 896-908. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16943402">[More Information]</a>
Lubik, S., Fogel, W., Tronnier, V., Krause, M.,
König, J., Jost, W. (2006). Gait analysis in
patients with advanced Parkinson disease:
different or additive effects on gait induced by
levodopa and chronic STN stimulation. Journal
of Neural Transmission, 113(2), 163-173. <a
href="http://dx.doi.org/10.1007/s00702-005-031
0-8">[More Information]</a>
Krause, M., Fogel, W., Tronnier, V., Pohle, S.,
Hörtnagel, K., Thyen, U., Volkmann, J. (2006).
Long-term benefit to pallidal deep brain
stimulation in a case of dystonia secondary to
pantothenate kinase-associated
neurodegeneration. Movement Disorders, 21(12),
2255-2257. <a
href="http://dx.doi.org/10.1002/mds.21166">[M
ore Information]</a>
Kupsch, A., Benecke, R., Müller, J., Trottenberg,
T., Schneider, G., Poewe, W., Eisner, W.,
Wolters, A., Krause, M., et al (2006). Pallidal
deep-brain stimulation in primary generalized or
segmental dystonia. New England Journal of
Medicine, 355(19), 1978-1990. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17093249">[More Information]</a>
2004
Krause, M., Fogel, W., Mayer, P., Kloss, M.,
Tronnier, V. (2004). Chronic inhibition of the
subthalamic nucleus in Parkinson's disease.
Journal of the Neurological Sciences, 219(1-2),
119-124. <a
href="http://dx.doi.org/10.1016/j.jns.2004.01.004
">[More Information]</a>
Schroeder, U., Kuehler, A., Hennenlotter, A.,
Haslinger, B., Tronnier, V., Krause, M., Pfister,
R., Sprengelmeyer, R., Lange, K.,
Ceballos-Baumann, A. (2004). Facial expression
recognition and subthalamic nucleus stimulation.
Journal of Neurology, Neurosurgery and
Psychiatry, 75(4), 648-650.
Krause, M., Fogel, W., Kloss, M., Rasche, D.,
Volkmann, J., Tronnier, V. (2004). Pallidal
stimulation for dystonia. Neurosurgery, 55(6),
1361-1368.
2003
Veltkamp, R., Krause, M., Schranz, C., Meinck,
H. (2003). Progressive arm weakness and tonic
hand spasm from multifocal motor neuropathy in
the brachial plexus. Muscle and Nerve, 28(2),
242-245. <a
href="http://dx.doi.org/10.1002/mus.10409">[M
ore Information]</a>
Schroeder, U., Kuehler, A., Lange, K., Haslinger,
B., Tronnier, V., Krause, M., Pfister, R.,
Boecker, H., Ceballos-Baumann, A. (2003).
Subthalamic nucleus stimulation affects a
frontotemporal network: a PET study. Annals of
Neurology, 54(4), 445-450. <a
href="http://dx.doi.org/10.1002/ana.10683">[Mo
re Information]</a>
Download